We are live on
!
Find out more
LCS
Levin Capital Strategies Portfolio holdings
AUM
$1.49B
1-Year Est. Return
30.44%
This Fund
S&P 500
This Quarter
Est. Return
+2.39%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$5.56B
AUM Growth
–
Cap. Flow
+$5.58B
Cap. Flow
% of AUM
100.52%
Top 10 Holdings %
Top 10 Hldgs %
34.75%
Holding
318
New
318
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$284M |
| 2 |
Eaton
ETN
|
+$281M |
| 3 |
Citigroup
C
|
+$238M |
| 4 |
PG&E
PCG
|
+$193M |
| 5 |
Molson Coors Class B
TAP
|
+$173M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.42% |
| 2 | Healthcare | 16.25% |
| 3 | Technology | 12.9% |
| 4 | Consumer Staples | 12.08% |
| 5 | Industrials | 11.44% |
Similar funds
ACB
MFWP
FCM
PMG
RG
TIA
MM
WA
Levin Capital Strategies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Levin Capital Strategies, which disclosed 318 positions worth $5.56B. Its ten largest holdings account for 35% of the portfolio.
Its largest position is Pfizer: 10,274,072 shares worth $273M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Healthcare and Technology.
- Levin Capital Strategies's largest Q2 2013 buy was Pfizer: 10,274,072 shares worth $273M.
- Levin Capital Strategies's ten largest holdings make up 35% of its $5.56B portfolio in Q2 2013.
- Levin Capital Strategies disclosed 318 positions in Q2 2013, its first 13F filing on record.
Based on Levin Capital Strategies's 13F filing for Q2 2013, filed 13 Aug 2013.